scholarly journals Insights From Veterinary Disciplinary Actions in California 2017–2019

2021 ◽  
Vol 8 ◽  
Author(s):  
Jake Labriola ◽  
Rebecca Garabed ◽  
Carly Sinclair ◽  
Antoinette E. Marsh
Keyword(s):  
Standard Of Care ◽  
Educational Interventions ◽  
Medical Community ◽  
Summary Statistics ◽  
Disciplinary Actions ◽  
Veterinary Students ◽  
Consumer Complaints ◽  
Temporal Aspect

There is increasing concern within the veterinary medical community (veterinarians and veterinary students) that disgruntled clients are unfairly leveraging various legal tools against veterinarians. Clinical veterinarians and veterinary students should be aware of the most common types of problems arising within the clinic and how they can lead to formal consumer complaints. The study describes and categorizes with greater detail the types of violations or “causes for discipline” that occur, as well as specific sanctions imposed on veterinarians formally disciplined for standard of care-related violations between 2017 and 2019, for California. In addition, the study calculated the frequency of disciplinary actions and their basic summary statistics regarding the temporal aspect of how lawsuits typically unfold. Using public documents from California, the study describes the analysis and trends for the purpose of providing contextual evidence to inform and guide potential veterinary educational interventions. Although specific to California, this study can serve as a template methodology for comparisons to other states.

scholarly journals Diagnostics of Cognitive Function in Women of Menopausal Period at Level of Primary Health Care

2014 ◽  
Vol 3 ◽  
Author(s):  
N. Zhilgeldina ◽  
T. Ulykbassova
Keyword(s):  
Cognitive Function ◽  
Cognitive Deficits ◽  
Transition Period ◽  
Hormone Replacement ◽  
Standard Of Care ◽  
Medical Community ◽  
Adequate Treatment ◽  
Care Services ◽  
Menopausal Women ◽  
Definition Of

Introduction. In the medical community, there is no consensus on whether or not climacteric changes are pathologic and require treatment. One of the main problems related to menopause is misperception of menopause; consequently, there is no consensus on treatments for psychological dysfunction and cognitive deficits in menopausal women. Timely diagnosis and adequate treatment of psychological disorders and cognitive dysfunction are imperative and complicated. The purpose of this study was to evaluate physician perceptions of cognitive and psychological deficits in menopausal women in outpatient settings.Methods. 215 obstetricians-gynecologists working in out-patient services were surveyed using a multiple choice questionnaire assessing perceptions and knowledge of menopausal transition.Results. Of total respondents, 42.0% ± 2.5 of physicians found it hard to define menopausal period, and 67.5% ± 3.2 could not give a clear definition of hormone replacement therapy. On the question “cognitive function includes…,” 62.5% ± 2.1 of physicians selected “memory,” 32.3% ± 1.8 selected attention, 77.5% ± 3.2 selected mood and/or imagination, 37.4% selected intellect, 36.3% ± 3.1 of respondents selected character traits, and 6.2% ± 1.7 selected speech. Regarding the question “how do you study memory status function?” it was estimated that 71.2% ± 2.5 of study participants have studied the memory only on the basis of subjective complaints, and none of the respondents (100%) have ever used neuropsychological tests.Conclusion. The survey allows us to ascertain that primary medical care services lack the ability to appropriately recognize and diagnose cognitive deficits in women of menopausal age. Based on these data, we can assume that proper mental care is not provided. Thus, the study indicates a need to create training programs for general practitioners and other specialists (cardiologists, neurologists, and endocrinologists) to fulfill this need. Implementation of a standard of care, testing, and treatment of cognitive and psychological function, such as the use of neuropsychological tests and questionnaires, in an out-patient setting for menopausal women would improve the quality of life during a woman’s transition period.

scholarly journals Conscientious Objection to Animal Testing: A Preliminary Survey Among Italian Medical and Veterinary Students

2019 ◽  
Vol 47 (1) ◽  
pp. 30-38 ◽  
Author(s):  
Ilaria Baldelli ◽  
Bartolomeo Biolatti ◽  
Pierluigi Santi ◽  
Giovanni Murialdo ◽  
Anna Maria Bassi ◽  
...  
Keyword(s):  
Veterinary Medicine ◽  
Educational Interventions ◽  
Animal Experimentation ◽  
Human Medicine ◽  
Animal Testing ◽  
Ethical Considerations ◽  
Veterinary Students ◽  
Knowledge And Attitudes ◽  
Italian Law ◽  
The Right

The use of animals for educational and research purposes is common in both veterinary and human medicine degree courses, and one that involves important ethical considerations. The aim of this study was to assess the extent of differences between the knowledge and attitudes of veterinary students and medical students on animal bioethics, on alternative strategies and on their right to conscientiously object to animal experimentation. To this end, a questionnaire was completed by 733 students (384 human medicine students (HMS) and 349 veterinary medicine students (VMS)). VMS were more aware than HMS (72.2% and 59.6%, respectively) of the existence of an Italian law on the right to conscientiously object to animal experimentation. However, very few of them had exercised this right. Many VMS (43.3%) felt that animal bioethics courses should be mandatory (only 17.4% of HMS felt the same way). More VMS than HMS (81.7% and 59.1%, respectively) expressed an interest in attending a course on alternatives to animal experimentation. The data suggest the need for appropriate educational interventions, in order to allow students to make choices based on ethical principles. Fostering close collaborations between departments of human medicine and veterinary medicine, for example, through shared study modules, could promote the development of ethical competence as a basic skill of students of both veterinary and human medicine courses.

scholarly journals They have Arrived! How Dallas, Texas Provided Shelter-Based Onsite Medical Care to Evacuees from Hurricane Harvey

2019 ◽  
Vol 34 (s1) ◽  
pp. s44-s45
Author(s):  
Lindsay A. Flax ◽  
E. Liang Liu ◽  
Kelly R. Klein ◽  
Raymond L. Fowler ◽  
Raymond E. Swienton
Keyword(s):  
Medical Care ◽  
Care Delivery ◽  
Large Population ◽  
Standard Of Care ◽  
Medical Community ◽  
Medical Decision ◽  
Medical Services ◽  
Additional Patient ◽  
Adult Care ◽  
Epidemiologic Surveillance

Introduction:After Hurricane Harvey and the flooding that ensued, 3,829 displaced persons were transported from their homes and sheltered in the Dallas Convention Center. This large general population sheltering operation was medically supported by the onsite Mega-Shelter Medical Clinic (MMC). In an altered standard of care environment, a number of multi-disciplinary medical services were provided including emergent management, acute pediatric and adult care, psychiatric/behavioral services, onsite pharmaceutical, and durable medical equipment distribution, epidemiologic surveillance, and select laboratory services.Aim:To describe how onsite medical care in the adapted environment of a large population shelter can provide comparable services and limit the direct impact on the local medical community.Methods:A retrospective chart review of medical records was generated for all clinical encounters at the MMC. Data were sorted by daily census, disease surveillance, medical decision making, treatment, and transport destinations.Results:40.7% of registered evacuees utilized the MMC accounting for a total of 2,654 clinic visits by 1,560 unique patients representing all age groups. During the sustained MMC operations, 8% of patients required emergency transport and 500 additional patient transports were arranged for clinic appointments. No deaths occurred and no iatrogenic morbidity was reported.Discussion:Medical care was provided for a large number of evacuees which mitigated the potential impact on the local medical infrastructure. The provision of medical services in a large population shelter may necessitate adaptation to the standard of care. However, despite the nontraditional clinical setting, care delivery was not compromised.

scholarly journals Help-Seeking Beliefs Among Anabolic Androgenic Steroid Users Experiencing Side Effects: An Interpretive Phenomenological Analysis

2020 ◽  
Vol 14 (4) ◽  
pp. 359-375
Author(s):  
Hugh Gilmore ◽  
Stephen Shannon ◽  
Gerard Leavey ◽  
Martin Dempster ◽  
Shane Gallagher ◽  
...  
Keyword(s):  
Side Effects ◽  
Interpretative Phenomenological Analysis ◽  
Help Seeking ◽  
Educational Interventions ◽  
Phenomenological Analysis ◽  
Medical Community ◽  
Professional Help ◽  
Recreational Athletes ◽  
The United Kingdom ◽  
Androgenic Steroids

Recreational athletes comprise the most prevalent population using illegal Anabolic Androgenic Steroids (AAS). Despite regulatory efforts, substances are widely accessible, and most users report the experience of harmful side effects. It remains unclear why few users seek professional medical help. The aim of this study was to determine AAS users’ experience of side effects and help-seeking beliefs using an Interpretative Phenomenological Analysis of six interviews. Participants were from the United Kingdom (n = 5) and United States (n = 1), had all experienced side effects, with some reporting prolonged use of AAS (>10 years) and self-manufacturing the drugs from raw ingredients. Results showed that AAS users discredit medical professionals’ competencies, and practice cognitive dissonance by avoiding challenging situations. A microculture for information-sharing has developed among AAS users who initially self-treat to counteract side effects, leaving them vulnerable to further harm. To conclude, there is an urgent need for educational interventions that outline the risky practice of unregulated AAS use and self-treatments, and the need to seek professional help. Such interventions could be developed through a co-production basis, and be implemented by current/former AAS users alongside the medical community.

scholarly journals Cutaneous wound healing: Current concepts and advances in wound care

2014 ◽  
Vol 47 (03) ◽  
pp. 303-317 ◽  
Author(s):  
Kenneth C Klein ◽  
Somes Chandra Guha
Keyword(s):  
Wound Healing ◽  
Wound Care ◽  
Standard Of Care ◽  
Medical Community ◽  
Medical Society ◽  
Cutaneous Wounds ◽  
General Acceptance ◽  
Healing Wound ◽  
The Usa ◽  
Variable Success

ABSTRACTA non-healing wound is defined as showing no measurable signs of healing for at least 30 consecutive treatments with standard wound care.[1] It is a snapshot of a patient’s total health as well as the ongoing battle between noxious factors and the restoration of optimal macro and micro circulation, oxygenation and nutrition. In practice, standard therapies for non-healing cutaneous wounds include application of appropriate dressings, periodic debridement and eliminating causative factors.[2] The vast majority of wounds would heal by such approach with variable degrees of residual morbidity, disability and even mortality. Globally, beyond the above therapies, newer tools of healing are selectively accessible to caregivers, for various logistical or financial reasons. Our review will focus on the use of hyperbaric oxygen therapy (HBOT), as used at our institution (CAMC), and some other modalities that are relatively accessible to patients. HBOT is a relatively safe and technologically simpler way to deliver care worldwide. However, the expense for including HBOT as standard of care for recognized indications per UHMS(Undersea and Hyperbaric Medical Society) may vary widely from country to country and payment system.[3] In the USA, CMS (Centers for Medicare and Medicaid Services) approved indications for HBOT vary from that of the UHMS for logistical reasons.[1] We shall also briefly look into other newer therapies per current clinical usage and general acceptance by the medical community. Admittedly, there would be other novel tools with variable success in wound healing worldwide, but it would be difficult to include all in this treatise.

Training Surgical Residents Utilizing an Animal Shelter Fracture Program

2021 ◽  
Author(s):  
Barbro Filliquist ◽  
Amy S. Kapatkin ◽  
Karen M. Vernau ◽  
Jamie Y. Nakatani ◽  
Po-Yen Chou ◽  
...  
Keyword(s):  
Surgical Care ◽  
Standard Of Care ◽  
Skills Training ◽  
Teaching Hospitals ◽  
Fracture Treatment ◽  
Veterinary Students ◽  
Surgical Resident ◽  
Case Load ◽  
Surgical Residents ◽  
Operative Care

Working relationships between veterinary medical teaching hospitals, animal shelters, and rescue groups are one way to increase veterinary students’ and residents’ hands-on training. The goal of this study is to describe the use of a shelter fracture program to improve the surgical skills of surgical residents. In this program, the participating shelter and rescue organizations electronically submit cases. Following evaluation of radiographs and case approval by the orthopedic faculty, the case is scheduled for a physical evaluation. A resident takes primary surgical care together with a fourth-year student rotating through the orthopedic surgery service to ensure the proper pre-, peri-, and post-operative standard of care. All care is overseen by the orthopedic faculty. A veterinary student–run fracture foster program allows students to gain additional experience in the pre-, peri-, and post-operative care of shelter animals. The total number of shelter animals treated during a 9-year period was 373, with a mean annual case load of 41.1 cases (± 10.3). During the same time period, a total of 435 client-owned cases underwent surgical fracture treatment, with a mean annual case load of 48 cases (± 11.7). Surgical resident and student surveys show that this program contributes to their knowledge, skills, and confidence in treating fracture patients. A successful cooperative program provides advanced surgical fracture treatment of shelter animals, improving animals’ quality of life as well as surgical residents’ and veterinary students’ skills training.

scholarly journals Preconception Care: A New Standard of Care within Maternal Health Services

2016 ◽  
Vol 2016 ◽  
pp. 1-30 ◽  
Author(s):  
Stephen J. Genuis ◽  
Rebecca A. Genuis
Keyword(s):  
Health Professionals ◽  
Preconception Care ◽  
Lifestyle Modification ◽  
Scientific Evidence ◽  
Standard Of Care ◽  
Maternal Health Services ◽  
Research Literature ◽  
Patient Choice ◽  
Medical Community ◽  
Prenatal Factors

Emerging research suggests that much pediatric affliction has origins in the vulnerable phase of fetal development. Prenatal factors including deficiency of various nutrients and exposure to assorted toxicants are major etiological determinants of myriad obstetrical complications, pediatric chronic diseases, and perhaps some genetic mutations. With recent recognition that modifiable environmental determinants, rather than genetic predestination, are the etiological source of most chronic illness, modification of environmental factors prior to conception offers the possibility of precluding various mental and physical health conditions. Environmental and lifestyle modification through informed patient choice is possible but evidence confirms that, with little to no training in clinical nutrition, toxicology, or environmental exposures, most clinicians are ill-equipped to counsel patients about this important area. With the totality of available scientific evidence that now exists on the potential to modify disease-causing gestational determinants, failure to take necessary precautionary action may render members of the medical community collectively and individually culpable for preventable illness in children. We advocate for environmental health education of maternity health professionals and the widespread adoption and implementation of preconception care. This will necessitate the translation of emerging knowledge from recent research literature, to health professionals, to reproductive-aged women, and to society at large.

scholarly journals Real-World Data on Frontline (FL) Treatments in Multiple Myeloma (MM) Patients across EU5 Countries

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 5858-5858
Author(s):  
Joana Anjo ◽  
Alex Rider ◽  
Abigail Bailey ◽  
Maren Gaudig
Keyword(s):  
Data Collection ◽  
Real World ◽  
Stem Cell Transplant ◽  
Standard Of Care ◽  
Cell Transplant ◽  
Summary Statistics ◽  
Real World Data ◽  
World Data ◽  
Induction Regimen ◽  
Number Of Cycles

Abstract Objective This analysis was conducted to understand the clinical practice on FL treatment in patients with MM across EU5 countries. Methods Real world data were collected through Adelphi's Disease-Specific ProgrammeTM - a point in time survey administered to physicians (n=241) in EU5 countries between Nov 2017 - Feb 2018. Stem Cell Transplant eligibility and treatments, including number of cycles and dosage, were collected from patient record forms (n=1952). Summary statistics were reported and analysed descriptively. Results Data on FL treatment was collected for 1952 patients; 988 (51%) were still on FL treatment at the time of data collection. Bortezomib-based regimens were used in more than 70% of patients - in both transplanted/transplant eligible (TE, n=572) and non-transplanted/transplant ineligible patients (TIE, n= 1380). In TIE patients, bortezomib, melphalan and dexamethasone (VMP) was the most commonly used regimen, covering almost one third of the patients (31%), followed by bortezomib, either in combination with cyclophosphamide and dexamethasone (VCD, 10%) or thalidomide and dexamethasone (VTD, 10%). The other two FL regimens currently approved in Europe - thalidomide, melphalan and dexamethasone (MPT) and lenalidomide and dexamethasone (Rd) have patient shares of 9% each. When analyzing the TIE patients undergoing FL treatment at time of data collection (n=606), VMP remained the most used regimen (29%) and Rd the second (15%), with VTD and MPT being used in 8% of patients. In TE patients, VTD was the most commonly used induction regimen, being used in 50% of patients, followed by VCD (21%). The numbers remained the same when analyzing the TE patients in FL treatment at time of data collection (n=382), with 54% and 22% using VTD and VCD, respectively. Conclusions Collectively these results indicate that bortezomib-based regimens remain the standard of care in FL treatment of MM in EU5, in both transplant and non-transplant settings. Disclosures Anjo: Janssen: Employment. Rider:Adelphi Real World: Employment. Bailey:Adelphi Real World: Employment. Gaudig:Janssen: Employment.

Patient-initiated approach to prevent oxaliplatin induced peripheral neuropathy: A social media experiment.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e16140-e16140
Author(s):  
Dana Cardinas ◽  
Manju George ◽  
Amber Norton ◽  
Renee Gentzel
Keyword(s):  
Clinical Trial ◽  
Social Media ◽  
Peripheral Neuropathy ◽  
Standard Of Care ◽  
Medical Community ◽  
Entire Group ◽  
Caregiver Support ◽  
Large Patient ◽  
Use Of Social Media ◽  
Hands And Feet

e16140 Background: Oxaliplatin continues to be the standard of care in the adjuvant and palliative setting in colorectal cancer (CRC). Although effective in CRC treatment, it is associated with a high risk of chemotherapy induced peripheral neuropathy (CIPN), which can debilitate the patient, prevent completion of care, and deteriorate their quality of life. Methods: Colontown is a Facebook-based CRC patient and caregiver support, education and advocacy group. Live Wire, a Colontown neighborhood that was formed in 2018 to help members manage CIPN, consists of over 700 CRC patients. One member of this group applied ice on hands and feet (‘icing’) during oxaliplatin infusion to limit exposure to chemotherapy via cold-induced vasoconstriction. The member was able to prevent CIPN, gaining the attention of the entire group. Results: Subsequently, popularization of icing occurred, as administrators communicated patient experiences and relayed published results on the effect of oral icing to patients. Several Colontown members voluntarily tried it during their chemotherapy, and reported successful outcomes. Live Wire created an “icing protocol” and distributed it to patients, oncologists, and care teams, both in-person and on social media (sm). Conclusions: This real-world example highlights the role of educated patient advocates on sm. Working with these groups directly can provide insights for the medical community on measures patients can do to prevent chemotherapy-associated side effects. The limited publications on icing to prevent CIPN, although promising, have not been enough to make it a recommended standard practice. Meanwhile, voluntary participation using icing for CIPN is growing in Colontown. At this time, Colontown is discussing with oncologists and cancer centers the potential of creating a clinical trial to verify the efficacy icing has during oxaliplatin infusion as a strategy to counter CIPN. Our hope is that this patient-informed icing protocol will be able to guide the design of a clinical trial on icing. Furthermore, with this “experiment”, we hope to illustrate the advantages of serious engagement with a large patient population through the modern use of social media.

Atezolizumab in advanced hepatocellular carcinoma: good things come to those who wait

Immunotherapy ◽  
2021 ◽  
Author(s):  
Alessandro Rizzo ◽  
Angela Dalia Ricci ◽  
Giovanni Brandi
Keyword(s):  
Hepatocellular Carcinoma ◽  
Checkpoint Inhibitors ◽  
Standard Of Care ◽  
Phase Iii ◽  
Medical Community ◽  
Advanced Hepatocellular Carcinoma ◽  
Novel Treatments ◽  
Treatment Naïve ◽  
The Impact

Advanced hepatocellular carcinoma (HCC) patients present poor prognosis. However, recent years have seen the advent of several novel treatments in this setting, where the role of immune checkpoint inhibitors has been investigated. Among these, the PD-L1 inhibitor atezolizumab in combination with bevacizumab has reported unprecedented results in treatment-naive patients with unresectable disease, with the recently published IMbrave150 Phase III trial showing the superiority of the combination over sorafenib monotherapy, and after having attended more than a decade of ‘stagnation’, the HCC medical community has a new standard of care. Herein, we examine the development and the impact of atezolizumab in advanced HCC, summarizing the mechanism of action, pharmacokinetics and recent evidence from Phase I to III clinical trials.

Sign in / Sign up

Export Citation Format

Share Document